Get started
RocketTickers

Aldeyra Therapeutics Receives Orphan Drug Designation from the U

Long
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)  
RocketTickers  
NASDAQ:ALDX   Aldeyra Therapeutics, Inc.
Beyond Technical Analysis
0
0
beyondta
ALDX: Aldeyra Therapeutics, Inc.
2021-08-04 08:00:00
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.